← Eichor
Study identifier: NCT07419321 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Social Isolation and Aging in Schizophrenia

Condition: Schizophrenia and Related Disorders  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseN/A
Planned participants650
Who can joinAll sexes, 40 Years to 70 Years
Healthy volunteersYes

About this study

Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk of premature mortality, with a 10-20-year shorter lifespan relative to the general population. Increased mortality rates in SZ are largely attributable to the early manifestation of medical conditions that normally occur later in life, a process known as 'accelerated aging'. While unhealthy lifestyle behaviors, such as smoking and unhealthy diet, account, in part, for accelerated aging in SZ, the excess of physical comorbidities cannot be solely attributed to these factors. Remarkably, the direct adverse health effects of key clinical characteristics of SZ have rarely been considered. In the general population, the absence of social contact is known to pose enormous challenges for physical health, especially at older ages. Given that social isolation is a persistent and disabling feature of SZ, it is possible that this behavior may contribute to the premature manifestation of health conditions in SZ. Building on rich pilot data pointing to significant associations between social isolation and long-term perceived health in SZ, the overarching goal is to test whether and how social isolation contributes to the health challenges of individuals with SZ as they age. With participants from Europe (EU-GEI) and the US (Olin Neuropsychiatry Research Center), the researchers will create a longitudinal database of 650 participants, including 500 individuals with SZ, and 150 of …

This description comes directly from the study's public registry record.

Talk to the study team

Eva Velthorst, PhD  ·  +31618644345  ·  e.velthorst@ggz-nhn.nl

Always discuss trial participation with your own doctor first.

Locations (4)

Olin Neuropsychiatry Research Center, HartfortHartford, Connecticut, United StatesRecruiting
AUMC, University HospitalAmsterdam, North Holland, NetherlandsRecruiting
Hospital General Universitario Gregorio MarañonMadrid, SpainRecruiting
King's College LondonLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07419321